Dr. Tamara Wexler is a Clinical Assistant Professor in the Department of Rehabilitation Medicine at NYU Langone Medical Center. Dr. Wexler established the Endocrine Patient Registry to support clinical research, and multidisciplinary and inter-institute research collaboration to further investigate the importance of pituitary dysfunction, and its treatment. She serves as principal investigator of the TBI/Pituitary Registry and the lead site investigator for a multisite neuroendocrine tumor study. Her research interests are focused on neuroendocrine and reproductive endocrine changes that may occur, including after traumatic brain injury. Her medical degree and PhD are from the University of Pennsylvania. She did her residency in Internal Medicine at the Massachusetts General Hospital. Dr. Wexler also had a fellowship at MGH involving Endocrinology, Diabetes, and Metabolism.

This is the second of a two-part interview. In Part Two, Dr. Wexler discusses the role played by other factors, such as age, gender, and race/ethnicity in pituitary dysfunction following a TBI; hypopituitarisms and the extent of pituitary dysfunction and the amount of time that elapses after a TBI; determining when it is appropriate to conduct screening; and the degree to which incidence and prevalence data indicate the mount of progress being made in treating pituitary problems.